HUTCHMED (LON:HCM) Stock Passes Below 200 Day Moving Average of $317.13

HUTCHMED (China) Limited (LON:HCMGet Rating) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 317.13 ($3.89) and traded as low as GBX 195.80 ($2.40). HUTCHMED shares last traded at GBX 200 ($2.45), with a volume of 56,547 shares trading hands.

Separately, Citigroup restated a “buy” rating and set a GBX 220 ($2.70) price target on shares of HUTCHMED in a research note on Thursday, June 23rd.

The stock has a market cap of £1.91 billion and a P/E ratio of -10.98. The company has a debt-to-equity ratio of 3.75, a current ratio of 3.89 and a quick ratio of 3.73. The business’s 50 day simple moving average is GBX 184.34 and its 200 day simple moving average is GBX 315.07.

HUTCHMED Company Profile (LON:HCM)

HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for CRC, breast cancer, GC, endometrial cancer (EMC), NSCLC, hepatocellular carcinoma, and gastrointestinal and solid tumors.

Further Reading

Receive News & Ratings for HUTCHMED Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HUTCHMED and related companies with MarketBeat.com's FREE daily email newsletter.